Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,871,082
-$5,801,464 QoQ
Shares Held
39,227
-45.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#922
of 4,153 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COMMERZBANK AKTIENGESELLSCHAFT /FI holds $332,070,617 across 8 Drug Manufacturers - General names. ABBV ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
630,281 | $160,072,465 | |
| 2 | AMGN |
Amgen Inc
|
209,478 | $75,856,173 | |
| 3 | LLY |
ELI LILLY & Co
|
34,683 | $41,599,834 | |
| 4 | MRK |
Merck & Co., Inc.
|
215,121 | $27,643,048 | |
| 5 | PFE |
Pfizer Inc
|
444,778 | $10,710,254 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
39,227 | $9,871,082 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
41,571 | $5,252,080 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,495 | $1,065,681 |
All Filings in ABBV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,871,082 | 39,227 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $15,672,546 | 72,061 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,144,847 | 79,412 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $20,862,217 | 90,102 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $24,072,685 | 129,688 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $12,418,250 | 59,270 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $10,037,206 | 56,484 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,344,873 | 37,193 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,533,007 | 14,768 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,878,725 | 10,317 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,359,861 | 8,775 | Shares | Sole | 2024-09-30 | |
| 2023-09-30 | $406,486 | 2,727 | Shares | Sole | 2024-09-30 | |
| 2022-09-30 | $796,670 | 5,936 | Shares | Sole | 2024-10-02 | |
| 2020-03-31 | $1,996,939 | 26,210 | Shares | Sole | 2024-10-03 | |
| No filing history on record for this holder in this stock. | ||||||